SCHEMBL812773

SCHEMBL812773

CC(C)(C)c1cc(C2(c3ccc(OCCO)c(C(C)(C)C)c3)c3ccccc3-c3ccccc32)ccc1OCCO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
PDK2 Q15119 5/20 0.41
KDM4E B2RXH2 7/20 0.40
ALDH1A1 P00352 4/20 0.40
GAA P10253 2/20 0.38
MAPK1 P28482 1/20 0.38
AR P10275 1/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
OPRK1 P41145 1/20 0.36
KMT2A Q03164 1/20 0.36
RARA P10276 2/20 0.35
RARB P10826 2/20 0.35
RARG P13631 2/20 0.35
IDO1 P14902 1/20 0.35
HTR7 P34969 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29407805 1.00 ESR1 (0.43) ESR1ESR2PDK2KDM4EALDH1A1
SCHEMBL29112874 0.89 ESR1 (0.35) ESR1ESR2PDK2KDM4EALDH1A1
SCHEMBL29009015 0.88 ESR1 (0.34) ESR1ESR2PDK2KDM4EALDH1A1
SCHEMBL29112939 0.87 SLC6A9 (0.39) ESR1ESR2PDK2CYP1A2CYP2D6
SCHEMBL4763014 0.84 ESR1 (0.45) ESR1ESR2PDK2KDM4EALDH1A1
SCHEMBL30063510 0.84 ESR1 (0.45) ESR1ESR2PDK2KDM4EALDH1A1
SCHEMBL346226 0.83 ESR1 (0.56) ESR1ESR2PDK2KDM4EALDH1A1
SCHEMBL30314588 0.83 ESR1 (0.56) ESR1ESR2PDK2KDM4EALDH1A1
SCHEMBL29385692 0.83 ESR1 (0.56) ESR1ESR2PDK2KDM4EALDH1A1
SCHEMBL20718779 0.82 ESR1 (0.41) ESR1ESR2PDK2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 471 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115703883-A Catalyst and preparation method of polycarbonate 华为技术有限公司 2023-02-17 CN claimed
CN-111825836-B Preparation method of polycarbonate 中国科学院过程工程研究所 2021-09-17 CN claimed
CN-111349223-B Composite catalyst for synthesizing polycarbonate by ester exchange method and preparation method of polycarbonate intermediate 中国科学院过程工程研究所 2021-06-18 CN claimed
CN-112812287-A Method for preparing polycarbonate by ionic liquid catalysis 中国科学院过程工程研究所 2021-05-18 CN claimed
CN-111825836-A Preparation method of polycarbonate 中国科学院过程工程研究所 2020-10-27 CN claimed
CN-111349223-A Composite catalyst for synthesizing polycarbonate by ester exchange method and preparation method of polycarbonate intermediate 中国科学院过程工程研究所 2020-06-30 CN claimed
US-12637540-B2 Resin produced by polycondensation, and resin composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-05-26 US disclosed
EP-4744853-A1 RECYCLED RESIN PRODUCTION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-05-20 EP disclosed
US-12617902-B2 Composition and siloxane-based thermoplastic resin using same, and methods for producing same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-05-05 US disclosed
EP-2371877-B1 POLYCARBONATE RESIN, POLYCARBONATE RESIN COMPOSITION, OPTICAL FILM, AND POLYCARBONATE RESIN MOLDED ARTICLE MITSUBISHI CHEM CORP (JP) 2026-04-29 EP disclosed
EP-4729558-A1 POLYCARBONATE RESIN, METHOD FOR PRODUCING SAME, AND OPTICAL LENS MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-04-22 EP disclosed
US-20260098129-A1 THERMOPLASTIC RESIN AND MOLDED BODY CONTAINING THERMOPLASTIC RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-04-09 US disclosed
US-12583966-B2 Curable resin, cured product thereof, resin composition, and method for producing curable resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-03-24 US disclosed
EP-2223951-A1 PROCESS FOR PRODUCTION OF POLYCARBONATE AND MOLDINGS OF POLYCARBONATE Mitsubishi Chemical Corporation (JP) 2010-09-01 EP disclosed
US-20100196720-A1 POLYCARBONATE RESIN AND OPTICAL FILM USING THE SAME ABB TECHNOLOGY LTD. (CH) 2010-08-05 US disclosed
US-7541416-B2 Comprises 30 to 70 mol % of a structural unit comprising a bisphenyl fluorene structure and 70 to 30 mol % of a structural unit comprising tricyclo [5.2.1.02.6] decanedimethanol and causes little occurrence of a birefringence; high transparency, excellent heat resistance; optics MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2009-06-02 US disclosed
EP-2053072-A1 POLYCARBONATE RESIN AND OPTICAL FILM USING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2009-04-29 EP disclosed
EP-1688451-B1 POLYCARBONATE COPOLYMER AND METHOD FOR PRODUCTION THEREOF MITSUBISHI GAS CHEMICAL CO (JP) 2008-03-19 EP disclosed
US-20070123685-A1 Polycarbonate copolymer and process for producing the same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2007-05-31 US disclosed
EP-1688451-A1 POLYCARBONATE COPOLYMER AND METHOD FOR PRODUCTION THEREOF MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2006-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583966-B2 Curable resin, cured product thereof, resin composition, and method for producing curable resin ARL1, ASH2L, SEM1 ESR1 2418/4885ESR2 1244/4885PDK2 4033/4885
US-12617902-B2 Composition and siloxane-based thermoplastic resin using same, and methods for producing same OR10J3, ASH2L, CCRL2 ESR1 422/4885ESR2 428/4885PDK2 3172/4885
US-12637540-B2 Resin produced by polycondensation, and resin composition TAF1, TAF5, PUF60 ESR1 758/4885ESR2 520/4885PDK2 4150/4885
US-20260098129-A1 THERMOPLASTIC RESIN AND MOLDED BODY CONTAINING THERMOPLASTIC RESIN RER1, EIF2AK1, RIOK1 ESR1 2292/4885ESR2 1471/4885PDK2 2865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.